• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白甲基酶和去甲基酶在抗肿瘤免疫中的作用:免疫治疗的新方向。

The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy.

机构信息

School of Medicine, Guizhou University, Guiyang, China.

Department of Gastrointestinal Surgery, Guizhou Provincial People's Hospital, Guiyang, China.

出版信息

Front Immunol. 2023 Jan 11;13:1099892. doi: 10.3389/fimmu.2022.1099892. eCollection 2022.

DOI:10.3389/fimmu.2022.1099892
PMID:36713412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9874864/
Abstract

Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.

摘要

表观遗传修饰可能改变正常细胞的增殖和分化,导致恶性转化。它们还可能影响组织微环境中免疫细胞的正常刺激、激活和异常功能。组蛋白甲基化由组蛋白甲基转移酶和组蛋白去甲基酶协调,以稳定启动子区域的转录水平,是最常见的表观遗传改变类型之一,越来越受到关注。它可以通过染色质结构修饰基因转录,并在转录组或蛋白质水平上影响细胞命运。根据最近的研究,组蛋白甲基化修饰可以调节肿瘤和免疫细胞,影响抗肿瘤免疫反应。因此,深入了解甲基化功能在癌症治疗中的作用至关重要。在这篇综述中,我们讨论了组蛋白甲基化对与肿瘤细胞免疫抵抗相关因素的作用以及对免疫细胞功能的调节的最新数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/0d2418f83e2f/fimmu-13-1099892-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/4702117459bc/fimmu-13-1099892-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/cf1a335c4f9f/fimmu-13-1099892-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/0d2418f83e2f/fimmu-13-1099892-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/4702117459bc/fimmu-13-1099892-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/cf1a335c4f9f/fimmu-13-1099892-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdd1/9874864/0d2418f83e2f/fimmu-13-1099892-g003.jpg

相似文献

1
The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy.组蛋白甲基酶和去甲基酶在抗肿瘤免疫中的作用:免疫治疗的新方向。
Front Immunol. 2023 Jan 11;13:1099892. doi: 10.3389/fimmu.2022.1099892. eCollection 2022.
2
Epigenetic cross-talk between DNA methylation and histone modifications in human cancers.人类癌症中 DNA 甲基化与组蛋白修饰的表观遗传串扰。
Yonsei Med J. 2009 Aug 31;50(4):455-63. doi: 10.3349/ymj.2009.50.4.455. Epub 2009 Aug 19.
3
[Advances in effector protein of histone methylation].[组蛋白甲基化效应蛋白的研究进展]
Yi Chuan. 2011 Apr;33(4):285-92. doi: 10.3724/sp.j.1005.2011.00285.
4
Epigenetic Regulation of Cancer Immune Cells.癌症免疫细胞的表观遗传调控。
Semin Cancer Biol. 2022 Aug;83:377-383. doi: 10.1016/j.semcancer.2021.06.022. Epub 2021 Jun 26.
5
Histone tales: lysine methylation, a protagonist in Arabidopsis development.组蛋白的故事:赖氨酸甲基化,拟南芥发育中的主角。
J Exp Bot. 2020 Jan 23;71(3):793-807. doi: 10.1093/jxb/erz435.
6
Protein methylation functions as the posttranslational modification switch to regulate autophagy.蛋白质甲基化作为一种翻译后修饰开关,调节自噬。
Cell Mol Life Sci. 2019 Oct;76(19):3711-3722. doi: 10.1007/s00018-019-03161-x. Epub 2019 Jun 19.
7
Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase.通过组蛋白甲基化和无毛组蛋白去甲基酶控制乳腺癌发病机制。
Endocrinology. 2021 Aug 1;162(8). doi: 10.1210/endocr/bqab088.
8
Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development.PU.1 启动子中的成熟相关组蛋白修饰调控 Th9 细胞的发育。
Blood. 2012 May 17;119(20):4665-74. doi: 10.1182/blood-2011-11-392589. Epub 2012 Mar 23.
9
Cross-talk among epigenetic modifications: lessons from histone arginine methylation.表观遗传修饰之间的串扰:组蛋白精氨酸甲基化的启示。
Biochem Soc Trans. 2013 Jun;41(3):751-9. doi: 10.1042/BST20130003.
10
The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.“表观遗传密码复制机制”(ECREM):一种有前景的可成药的表观遗传细胞记忆靶点。
Curr Med Chem. 2007;14(25):2629-41. doi: 10.2174/092986707782023244.

引用本文的文献

1
Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential.癌症中的甲硫氨酸依赖性与限制:探索致病功能和治疗潜力
Pharmaceuticals (Basel). 2025 Apr 28;18(5):640. doi: 10.3390/ph18050640.
2
Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery.乳腺癌中的表观遗传修饰:从免疫逃逸机制到治疗靶点发现
Front Immunol. 2025 Apr 17;16:1584087. doi: 10.3389/fimmu.2025.1584087. eCollection 2025.
3
Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations.

本文引用的文献

1
A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.一项泛癌分析揭示赖氨酸(K)特异性去甲基化酶6B在肿瘤发生和免疫中的双重作用
Front Genet. 2022 Jun 14;13:912003. doi: 10.3389/fgene.2022.912003. eCollection 2022.
2
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.靶向赖氨酸特异性去甲基化酶 1 可恢复主要组织相容性复合体 I 类抗原呈递并克服小细胞肺癌中程序性死亡配体 1 阻断耐药性。
J Thorac Oncol. 2022 Aug;17(8):1014-1031. doi: 10.1016/j.jtho.2022.05.014. Epub 2022 Jun 9.
3
揭示癌症干细胞治疗的未来:对新兴创新的叙事性探索。
Discov Oncol. 2025 Mar 22;16(1):373. doi: 10.1007/s12672-025-02102-4.
4
GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells.GRP78作为癌症治疗中的潜在治疗靶点:对其在癌细胞放化疗耐药中作用的最新综述
Med Oncol. 2025 Jan 18;42(2):49. doi: 10.1007/s12032-024-02586-0.
5
KDM4B mutations in human cancers.KDM4B 突变与人类癌症。
Mutat Res. 2024 Jul-Dec;829:111866. doi: 10.1016/j.mrfmmm.2024.111866. Epub 2024 Jun 11.
6
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.乳腺癌中肿瘤微环境的调节和基于免疫治疗的耐药机制。
Mol Cancer. 2024 May 7;23(1):92. doi: 10.1186/s12943-024-01990-4.
7
Methylation in cornea and corneal diseases: a systematic review.角膜及角膜疾病中的甲基化:一项系统综述。
Cell Death Discov. 2024 Apr 8;10(1):169. doi: 10.1038/s41420-024-01935-2.
8
Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.低级别胶质瘤中与铜死亡相关的基因定位 DNA 甲基化:预后和肿瘤微环境。
Cancer Biomark. 2024;40(2):185-198. doi: 10.3233/CBM-230341.
9
Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer.赖氨酸酰化(Kla)可能成为乳腺癌的一个新的治疗靶点。
BMC Med Genomics. 2023 Nov 10;16(1):283. doi: 10.1186/s12920-023-01726-1.
The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer.
Jmjd家族组蛋白去甲基化酶在炎症与癌症的相互作用中
Front Immunol. 2022 Apr 26;13:881396. doi: 10.3389/fimmu.2022.881396. eCollection 2022.
4
The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.环状 RNA circHMGB2 通过 miR-181a-5p/CARM1 轴驱动肺腺癌和鳞状细胞癌中的免疫抑制和抗 PD-1 耐药。
Mol Cancer. 2022 May 7;21(1):110. doi: 10.1186/s12943-022-01586-w.
5
Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer.KDM5家族在胰腺癌中的表达、预后价值及功能机制
Front Cell Dev Biol. 2022 Apr 13;10:887385. doi: 10.3389/fcell.2022.887385. eCollection 2022.
6
KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.大规模公共数据库和临床样本揭示的子宫体子宫内膜癌潜在预后生物标志物 KDM4B。
Mol Omics. 2022 Jul 11;18(6):506-519. doi: 10.1039/d1mo00287b.
7
Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.中国肺腺癌患者程序性细胞死亡配体1(PD-L1)表达的基因组相关性
Cancer Cell Int. 2022 Mar 27;22(1):138. doi: 10.1186/s12935-022-02488-z.
8
DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway.DOT1L 通过改变 T 细胞亚群和致癌途径影响结直肠癌的发生。
Oncoimmunology. 2022 Mar 16;11(1):2052640. doi: 10.1080/2162402X.2022.2052640. eCollection 2022.
9
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.LSD1 缺失降低胃癌细胞外泌体 PD-L1 并恢复 T 细胞反应。
Mol Cancer. 2022 Mar 16;21(1):75. doi: 10.1186/s12943-022-01557-1.
10
Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.肝细胞癌中组蛋白赖氨酸去甲基酶(KDMs)的预后生物标志物和免疫浸润的综合分析。
Cancer Immunol Immunother. 2022 Oct;71(10):2449-2467. doi: 10.1007/s00262-022-03167-8. Epub 2022 Mar 7.